PTK787/ZK222584 improves PFS when joined with FOLFOX4 - Comment Journal Article
| Author: | Lichtman, S. M. |
| Article Title: | PTK787/ZK222584 improves PFS when joined with FOLFOX4 - Comment |
| Keywords: | treatment outcome; overall survival; clinical trial; drug tolerability; fatigue; bevacizumab; fluorouracil; placebo; cancer combination chemotherapy; diarrhea; drug efficacy; drug withdrawal; hypertension; patient selection; risk benefit analysis; note; disease free survival; colorectal cancer; bleeding; irinotecan; protein tyrosine kinase inhibitor; dizziness; folinic acid; medical research; vatalanib; nausea and vomiting; lactate dehydrogenase; disease duration; metastasis potential; oxaliplatin; gastrointestinal disease; germany; hematologic disease; hypothesis |
| Journal Title: | The Oncology Report |
| Issue: | Fall |
| ISSN: | 1548-5323 |
| Publisher: | International Medical News Group LLC |
| Date Published: | 2006-09-01 |
| Start Page: | 43 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 4 June 2012" - "Source: Scopus" |
MSK Authors
-
228Lichtman